Filana Therapeutics (FLNA) Profit After Tax (2010 - 2026)

Filana Therapeutics' Profit After Tax history runs 17 years deep, the most recent figure standing at -$8.6 million for Q2 2026.

• In Q2 2026, Profit After Tax rose 80.55% year-over-year to -$8.6 million; the TTM figure through Jun 2026 stood at -$42.3 million (up 65.67% YoY), while the FY2025 annual figure was -$91.0 million, down 33.52% from the prior year.
• Profit After Tax for Q2 2026 stood at -$8.6 million, up from -$10.3 million in the prior quarter.
• The five-year high for Profit After Tax was $25.0 million in Q1 2024, with the low at -$44.2 million in Q2 2025.
• The 5-year median for Profit After Tax is -$19.8 million (2022), against an average of -$17.1 million.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 203.18% in 2024, then plunged 818.51% in 2025.
• Filana Therapeutics' Profit After Tax stood at -$19.1 million in 2022, then retreated by 9.33% to -$20.9 million in 2023, then slumped by 31.92% to -$27.6 million in 2024, then soared by 54.56% to -$12.5 million in 2025, then jumped by 31.39% to -$8.6 million in 2026.
• Business Quant data shows FLNA's Profit After Tax at -$8.6 million in Q2 2026, -$10.3 million in Q1 2026, and -$12.5 million in Q4 2025.